ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing and gene insertion to develop new medicines. To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines. ReNAgade Therapeutics – RNA Without Limits
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Total raised: $300M
Founded date: 2021
Investors 1
| Date | Name | Website |
| 18.05.2023 | MPM Capita... | mpmcapital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.05.2023 | Series A | $300M | MPM Capita... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 24.05.2023 | ReNAgade Therapeutics Raises Over $300M in Series A Financin... | ReNAgade Therapeutics, a Cambridge, MA-based biotechnology company developing RNA medicines, raised ... | finsmes.co... |
| - | ReNAgade Therapeutics: This Company Recently Raised Over $30... | ReNAgade Therapeutics – a company unlocking the limitless potential for RNA medicines to correct dis... | pulse2.com... |
| - | ReNAgade Therapeutics | “ReNAgade Therapeutics” | fastfounde... |